Thromb Haemost 2003; 90(04): 662-671
DOI: 10.1160/TH03-05-0269
Platelets and Blood Cells
Schattauer GmbH

Stejnulxin, a novel snake C-type lectin-like protein from Trimeresurus stejnegeri venom is a potent platelet agonist acting specifically via GPVI

Wen-Hui Lee
1   Department of Animal Toxinology, Kunming Institute of Zoology, The Chinese Academy of Sciences, Kunming, Yunnan, P. R. China
,
Xiao-Yan Du
2   Theodor Kocher Institute, University of Berne, Berne, Switzerland
,
Qiu-Min Lu
1   Department of Animal Toxinology, Kunming Institute of Zoology, The Chinese Academy of Sciences, Kunming, Yunnan, P. R. China
2   Theodor Kocher Institute, University of Berne, Berne, Switzerland
,
Kenneth J. Clemetson
2   Theodor Kocher Institute, University of Berne, Berne, Switzerland
,
Yun Zhang
1   Department of Animal Toxinology, Kunming Institute of Zoology, The Chinese Academy of Sciences, Kunming, Yunnan, P. R. China
› Author Affiliations
Further Information

Publication History

Received 06 May 2003

Accepted after revision 26 June 2003

Publication Date:
05 December 2017 (online)

Summary

Stejnulxin, a novel snake C-type lectin-like protein with potent platelet activating activity, was purified and characterized from Trimeresurus stejnegeri venom. Under non-reducing conditions, it migrated on a SDS-polyacrylamide gel with an apparent molecular mass of 120 kDa. On reduction, it separated into three polypeptide subunits with apparent molecular masses of 16 kDa (α), 20 kDa (β1) and 22 kDa (β2), respectively. The complete amino acid sequences of its subunits were deduced from cloned cDNAs. The N-terminal sequencing and cDNA cloning indicated that β1 and β2 subunits of stejnulxin have identical amino acid sequences and each contains two N-glycosylation sites. Accordingly, the molecular mass difference between β1 and β2 is caused by glycosylation heterogenity. The subunit amino acid sequences of stejnulxin are similar to those of convulxin, with sequence identities of 52.6% and 66.4% for the α and β, respectively. Stejnulxin induced human platelet aggregation in a dose-dependent manner. Antibodies against αIIbβ3 inhibited the aggregation response to stejnulxin, indicating that activation of αIIbβ3 and binding of fibrinogen are involved in stejnulxin-induced platelet aggregation. Antibodies against GPIbα or α2β1 as well as echicetin or rhodocetin had no significant effect on stejnulxin-induced platelet aggregation. However, platelet activation induced by stejnulxin was blocked by anti-GPVI antibodies. In addition, stejnulxin induced a tyrosine phosphorylation profile in platelets that resembled that produced by convulxin. Biotinylated stejnulxin bound specifically to platelet membrane GPVI.

 
  • References

  • 1 Nieuwenhuis HK, Akkerman JW, Houdijk W. et al. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 1985; 318: 470-2.
  • 2 Staatz WD, Walsh JJ, Pexton T. et al. The α2β1 integrin cell surface collagen receptor binds to the α1 (I)-CB3 peptide of collagen. J Biol Chem 1990; 265: 4778-81.
  • 3 Clemetson JM, Polgar J, Magnenat E. et al. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin super-family closely related to FcαR and the natural killer receptors. J Biol Chem 1999; 274: 29019-24.
  • 4 Tsuji M, Ezumi Y, Arai M. et al. A novel association of Fc receptor γ-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets. J Biol Chem 1997; 272: 23528-31.
  • 5 Asselin J, Gibbins JM, Achison M. et al. A collagen-like peptide stimulates tyrosine phosphorylation of syk and phospholipase Cγ2 in platelets independent of the integrin α2β1 . Blood 1997; 89: 1235-42.
  • 6 Polar J, Clemetson JM, Kehrel BE. et al. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J Biol Chem 1997; 272: 13576-83.
  • 7 Jandrot-Perrus M, Lagrue AH, Okuma M. et al. Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin α2β1 . J Biol Chem 1997; 272: 27035-41.
  • 8 Schulte V, Snell D, Bergmeier W. et al. Evidence for two distinct epitopes within collagen for activation of murine platelets. J Biol Chem 2001; 276: 364-8.
  • 9 Fujimura Y, Kawasaki T, Titani K.. Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib. Thromb Haemost 1996; 76: 633-39.
  • 10 Clemetson KJ, Polgar J, Clemetson JM. Snake venom C-type lectins as tools in platelet research. Platelets 1998; 9: 165-69.
  • 11 Clemetson KJ, Navdaev A, Dormann D. et al. Multifunctional snake C-type lectins affecting platelets. Haemostasis 2001; 31: 148-54.
  • 12 Andrews RK, Berndt MC. Snake venom modulators of platelet adhesion receptors and their ligands. Toxicon 2000; 38: 775-91.
  • 13 Andrews RK, Kroll MH, Ward CM. et al. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related Viper venom proteins to the platelet membrane glycoprotein Ib-I-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation. Biochemistry 1996; 35: 12629-39.
  • 14 Taniuchi Y, Kawasaki T, Fujimura Y. et al. Flavocetin-A and -B, two high molecular mass glycoprotein Ib binding proteins with high affinity purified from Trimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress. Biochim Biophys Acta 1995; 1244: 331-8.
  • 15 Leduc M, Bon C. Cloning of subunits of con-vulxin, a collagen-like platelet-aggregating protein from Crotalus durissus terrificus venom. Biochem J 1998; 333: 389-93.
  • 16 Du XY, Navdaev A, Clemetson JM. et al. Bilinexin, a snake C-type lectin from Agkistrodon bilineatus venom agglutinates platelets via GPIb and α2β1 . Thromb Haemost 2001; 86: 1277-83.
  • 17 Du XY, Magnenat E, Wells TNC. et al. Alboluxin, a snake C-type lectin from Trimeresurus albolabris venom is a potent platelet agonist acting via GPIb and GPVI. Thromb Haemost 2002; 87: 692-98.
  • 18 Du XY, Clemetson JM, Navdaev A. et al. Ophioluxin, a convulxin-like C-type lectin from Ophiophagus hannah (King cobra) is a powerful platelet activator via glycoprotein VI. J Biol Chem 2002; 277: 35124-32.
  • 19 Fukuda K, Mizuno H, Atoda H. et al. Crystal structure of flavocetin-A, a platelet glycoprotein Ib-binding protein, reveals a novel cyclic tetramer of C-type lectin-like heterodimers. Biochemistry 2000; 39: 1915-23.
  • 20 Dormann D, Clemetson JM, Navdaev A. et al. Alboaggregin A activates platelets by a mechanism involving glycoprotein VI as well as glycoprotein Ib. Blood 2001; 97: 929-36.
  • 21 Asazuma N, Marshall SJ, Berlanga O. et al. The snake venom toxin alboaggregin-A activates glycoprotein VI. Blood 2001; 97: 3989-91.
  • 22 Peng M, Lu W, Beviglia L. et al. Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood 1993; 81: 2321-8.
  • 23 Wang R, Kini RM, Chung MCM. Rhodocetin, a novel platelet aggregation inhibitor from the venom of Calloselasma rhodostoma (Malayan pit viper): synergistic and noncovalent interaction between its subunits. Biochemistry 1999; 38: 7584-93.
  • 24 Laemmli UK. Cleavage of structural proteins during the assembling of the head of bacterio-phage. Nature 1970; 227: 680-5.
  • 25 Xu Q, Wu XF, Xia QC. et al. Cloning of a galactose-binding lectin from the venom of Trimeresurus stejnegeri . Biochem J 1999; 341: 733-7.
  • 26 Matsuzaki R, Yoshihara E, Yamada M. et al. cDNA cloning of IX/-BP, a heterogeneous two-chain anticoagulant protein from snake venom. Biochem Biophys Res Commun 1996; 220: 382-7.
  • 27 Sakurai Y, Fujimura Y, Kokubo T. et al. The cDNA cloning and molecular characterization of a snake venom platelet glycoprotein Ib-binding protein, mamushigin, from Agkistrodon halys blomhoffii venom. Thromb Haemost 1998; 79: 1199-207.
  • 28 Zhang Y, Wisner A, Xiong Y. et al. A novel plasminogen activator from snake venom. Purification, characterization, and molecular cloning. J Biol Chem 1995; 270: 10246-55.
  • 29 Shin Y, Okuyama I, Hasegawa J. et al. Molecular cloning of glycoprotein Ib-binding protein, flavocetin-A, which inhibits platelet aggregation. Thromb Res 2000; 99: 239-47.
  • 30 Polgar J, Magnenat EM, Peitsch MC. et al. Amino acid sequence of the α°subunit and computer modelling of the α°and β°subunits of echicetin from the venom of Echis carinatus (saw-scaled viper). Biochem J 1997; 323: 533-7.
  • 31 Peng M, Holt JC, Niewiarowski S. Isolation, characterization and amino acid sequence of echicetin β°subunit, a specific inhibitor of von Willebrand factor and thrombin interaction with glycoprotein Ib. Biochem Biophys Res Commun 1994; 205: 68-72.
  • 32 Drickamer K. Evolution of Ca2+-dependent animal lectins. Prog Nucleic Acid Res Mol Biol 1993; 45: 207-32.
  • 33 Rudd PM, Elliott T, Cresswell P. et al. Glycosylation and the immune system. Science 2001; 291: 2370-6.
  • 34 Radaev S, Sun P. Recognition of immunoglobulins by Fcγ°receptors. Mol Immunol 2002; 38: 1073-83.